P0DTC1 (R1A_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)

Replicase polyprotein 1a UniProtKBInterProInteractive Modelling

4405 aa; Sequence (Fasta) ; 2 identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A6G7KRG6, A0A6G6A224

Available Structures

Host translation inhibitor nsp1 1-180; PRO_0000449635

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7k7p.1.Amonomer0.7610-126
100.00
Assess
6zoj.1.8monomer0.67148-180
100.00
Assess

Non-structural protein 2 181-818; PRO_0000449636

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7msw.1.Amonomer0.84184-818
ZN;100.00
Assess

Papain-like protease nsp3 819-2763; PRO_0000449637

DescriptionPDB IDOligo-stateRangeLigands
Structure of the SARS-COV2 PLpro (C111S) in complex with a dimeric Ubv that inhibits activity by an… Heteromer
P62987;
1565-1878
ZN;BR;
Assess
Crystal structures of SARS-CoV-2 papain-like protease in complex with covalent inhibitorshomo-2-mer1565-1877
ZN;
Assess
Crystal structure of the SARS-CoV-2 papain-like protease (PLPro) C112S mutantmonomer1563-1878
ZN;PO4;
Assess
Structure of SARS-CoV-2 Papain-like protease PLpro in complex with 3, 4-Dihydroxybenzoic acid, meth…monomer1564-1878
HE9;GOL;ZN;PO4;CL;
Assess
SARS-CoV-2 papain-like protease (PLpro) bound to inhibitor XR8-89monomer1564-1878
ZN;SO4;XT7;GOL;
Assess
SARS-CoV-2 papain-like protease (PLpro) bound to inhibitor XR8-83monomer1564-1878
ZN;SO4;BO3;Y54;
Assess
SARS-CoV-2 papain-like protease (PLpro) bound to inhibitor XR8-24monomer1564-1878
XR8;ZN;SO4;BO3;
Assess
SARS CoV-2 PLpro in complex with inhibitor 3kmonomer1566-1875
S88;ZN;DMS;
Assess
Crystal Structure of L516C/Y647C Mutant of SARS-Unique Domain (SUD) from SARS-CoV-2monomer1231-1489
FMT;ACT;SO4;
Assess
Structure of SARS-CoV-2 NSP3 macrodomain in the apo formmonomer1024-1192
CL;MPO;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6ywk.3.Amonomer0.841025-1194
100.00
Assess
6w9c.1.Amonomer0.801566-1878
ZN;100.00
Assess
3e9s.1.Amonomer0.791564-1877
TTT;ZN;82.86
Assess
7cmd.4.Amonomer0.791564-1878
TTT;ZN;100.00
Assess
2w2g.1.Amonomer0.791231-1494
75.00
Assess
6wuu.2.Amonomer0.791562-1879
ACE;ZN;99.69
Assess
2kqv.1.Amonomer0.751369-1493
78.13
Assess
2kqw.1.Amonomer0.711496-1550
80.22
Assess
2k87.1.Amonomer0.691907-2021
81.74
Assess

Non-structural protein 4 2764-3263; PRO_0000449638

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3vcb.1.Ahomo-2-mer0.723174-3262
61.36
Assess

3C-like proteinase nsp5 3264-3569; PRO_0000449639

DescriptionPDB IDOligo-stateRangeLigands
Structure of compound 12 bound to SARS-CoV-2 main proteasehomo-2-mer3264-3569
XJ9;CL;BR;EDO;NA;
Assess
Structure of compound 7 bound to SARS-CoV-2 main proteasehomo-2-mer3264-3569
XI0;GOL;BR;CL;EDO;NA;
Assess
Structure of compound 11 bound to SARS-CoV-2 main proteasehomo-2-mer3264-3569
XHW;PGE;BR;CL;GOL;NA;
Assess
CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE COMPLEXED WITH FRAGMENT F01homo-2-mer3264-3569
NA;DMS;5P9;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) A193P Mutant in Complex with Inhibitor Nirmatr…homo-2-mer3264-3569
4WI;
Assess
Structure of compound 8 bound to SARS-CoV-2 main proteasehomo-2-mer3264-3569
XH9;CL;DMS;NA;
Assess
Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (T21I) in complex with protease inhibit…homo-2-mer3264-3569
4WI;LQZ;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with…homo-2-mer3264-3569
4WI;
Assess
Crystal structure of SARS-CoV-2 Mpro-S144A mutant in complex with 13b-Khomo-2-mer3264-3569
O6K;
Assess
Crystal structure of SARS-CoV-2 Mpro in complex with cyclic peptide GM4 including unnatural amino a…homo-2-mer3264-3569
PEG;DMS;EDO;PGE;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) L167F Mutant in Complex with Inhibitor Nirmatr…homo-2-mer3264-3569
4WI;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 10homo-2-mer3264-3569
OZB;
Assess
Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (E166V) in complex with protease inhibi…homo-2-mer3264-3569
4WI;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with…homo-2-mer3264-3569
4WI;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) F140L Mutant in Complex with Inhibitor Nirmatr…homo-2-mer3264-3569
4WI;
Assess
Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro) in Complex with Nirmatrelvirhomo-2-mer3264-3569
4WI;
Assess
Crystal structure of SARS-CoV-2 main protease (Mpro) Mutant (S144A) in complex with protease inhibi…homo-2-mer3264-3568
4WI;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3homo-2-mer3264-3568
P0O;
Assess
Crystal structure of SARS CoV-2 3CL protease in complex with GSK4365097Ahomo-2-mer3264-3568
WTV;GOL;CL;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 1homo-2-mer3264-3568
OZ6;
Assess
Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro)homo-2-mer3264-3568
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 9 (simnotrelvir, SIM0417, SSD8432)homo-2-mer3264-3568
PQL;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 2homo-2-mer3264-3568
I1Z;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with nirmatrelvirhomo-2-mer3264-3568
4WI;
Assess
SARS-CoV-2 Mpro (Omicron, P132H) in complex with alpha-ketoamide 13b-K at pH 6.5homo-2-mer3264-3568
O6K;
Assess
Room-temperature X-ray structure of SARS-CoV-2 main protease double mutant E290A/R298A in complex w…homo-2-mer3264-3566
UED;
Assess
Crystal structure of the SARS-CoV-2 main protease in complex with SY110homo-2-mer3264-3566
LVX;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with Robinetinhomo-2-mer3264-3566
LKR;
Assess
SARS-CoV-2 Mpro Double Mutant (H41A and T21I) in complex with nsp4/5 peptidyl substratehomo-2-mer3264-3565
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) E166V Mutant in Complex with Inhibitor Enstrel…homo-2-mer3264-3565
7YY;GOL;
Assess
Crystal structure of SARS-CoV-2 Mpro-S144A mutant, free enzymehomo-2-mer3264-3565
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with…homo-2-mer3264-3565
7YY;VIB;GOL;
Assess
Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (T21I and E166V) in Complex with…homo-2-mer3264-3565
7YY;
Assess
Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with PF07321332homo-2-mer3266-3566
4WI;
Assess
Crystal Structure of SARS-CoV-2 Omicron Main Protease (Mpro) in Complex with Ensitrelvirhomo-2-mer3264-3564
7YY;
Assess
The crystal structure of SARS-CoV-2 3C-like protease Double Mutant (L50F and E166V) in complex with…homo-2-mer3264-3564
ODN;
Assess
Crystal structure of the SARS-CoV-2 main protease in complex with Hit-1homo-2-mer3264-3564
LV0;DMS;
Assess
The crystal structure of SARS-CoV-2 3CL protease in complex with Ensitrelvirhomo-2-mer3264-3563
7YY;
Assess
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 7homo-2-mer3264-3563
OZL;
Assess
Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with PF07321332homo-2-mer3266-3564
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with inhibitor YH-53homo-2-mer3265-3563
HUR;
Assess
Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with inhibitor YH-53homo-2-mer3266-3564
HUR;
Assess
Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF07321332homo-2-mer3266-3564
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with PF07304814homo-2-mer3266-3564
80I;
Assess
Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with inhibitor YH-53homo-2-mer3266-3564
HUR;
Assess
Crystal structure of SARS-Cov-2 main protease Y54C mutant in complex with PF07304814homo-2-mer3266-3564
80I;
Assess
Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with inhibitor YH-53homo-2-mer3266-3564
HUR;
Assess
Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF07304814homo-2-mer3266-3564
80I;
Assess
Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with PF07304814homo-2-mer3266-3564
80I;
Assess
Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with PF07304814homo-2-mer3266-3564
80I;
Assess
Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with PF07321332homo-2-mer3266-3563
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease in complex with S217622homo-2-mer3266-3563
7YY;
Assess
Crystal structure of SARS-Cov-2 main protease P132H mutant in complex with PF07321332homo-2-mer3266-3563
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease D48N mutant in complex with PF07321332homo-2-mer3266-3563
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with PF07304814homo-2-mer3266-3563
80I;
Assess
Crystal structure of SARS-Cov-2 main protease S46F mutant in complex with PF07321332homo-2-mer3266-3561
4WI;
Assess
Crystal structure of SARS-Cov-2 main protease D48N mutanthomo-2-mer3267-3561
Assess
SARS-CoV-2 Mpro (Omicron, P132H) free enzymemonomer3264-3568
Assess
SARS-COV2 Main Protease in complex with inhibitor MG-131monomer3264-3567
I8H;NA;
Assess
SARS-COV2 Main Protease in complex with inhibitor MG78monomer3264-3564
I70;CL;NA;
Assess
Mpro from SARS-CoV-2monomer3264-3563
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5rfv.1.Bhomo-2-mer0.913264-3567
T8J;100.00
Assess
5r7z.1.Bhomo-2-mer0.913264-3567
HWH;100.00
Assess
2z9j.1.Ahomo-2-mer0.893264-3567
DTZ;96.08
Assess
6lu7.1.Bhomo-2-mer0.893264-3569
100.00
Assess
6y2g.1.Ahomo-2-mer0.883264-3566
GLY;O6K;100.00
Assess
2a5i.1.Bhomo-2-mer0.873264-3569
AZP;96.08
Assess

Non-structural protein 7 3860-3942; PRO_0000449641

DescriptionPDB IDOligo-stateRangeLigands
SARS-CoV-2 RNA E-RTC complex with RMP-nsp9 and GMPPNP Heteromer
P0DTD1;
3861-3936
ZN;GNP;MG;F86;
Assess
SARS-CoV-2 E-RTC complex with RNA-nsp9 Heteromer
P0DTD1;
3861-3932
ZN;MN;
Assess
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mecha… Heteromer
P0DTD1;
3861-3932
13×ZN;MG;
Assess
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors Heteromer
P0DTD1;
3861-3932
ZN;MN;U5P;
Assess
SARS-CoV-2 E-RTC bound with MMP-nsp9 and GMPPNP Heteromer
P0DTD1;
3861-3932
ZN;GNP;6GS;
Assess
Structure of SARS-CoV-2 RNA-dependent RNA polymerase with gossypol binding Heteromer
P0DTD1;
3861-3916
GO3;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6m71.1.Bmonomer0.803861-3930
100.00
Assess
7jlt.1.Amonomer0.793860-3938
100.00
Assess
2ahm.1.Bmonomer0.753860-3933
98.80
Assess

Non-structural protein 8 3943-4140; PRO_0000449642

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ahm.1.Hmonomer0.773944-4134
97.47
Assess
7jlt.1.Dmonomer0.764019-4135
100.00
Assess
6nur.1.Bmonomer0.764019-4133
97.47
Assess
2ahm.1.Emonomer0.703980-4134
97.47
Assess
6m71.1.Dmonomer0.704020-4133
100.00
Assess

RNA-capping enzyme subunit nsp9 4141-4253; PRO_0000449643

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1qz8.1.Ahomo-2-mer0.794143-4253
97.35
Assess
6w4b.1.Ahomo-2-mer0.794141-4253
100.00
Assess
1uw7.1.Bhomo-2-mer0.734141-4253
97.35
Assess

Non-structural protein 10 4254-4392; PRO_0000449644

DescriptionPDB IDOligo-stateRangeLigands
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 1 Heteromer
P0DTD1;
4270-4385
MES;MTA;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 11 Heteromer
P0DTD1;
4270-4385
MES;A1H4D;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 5 Heteromer
P0DTD1;
4271-4385
MES;A1H28;GOL;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 7 Heteromer
P0DTD1;
4271-4385
MES;A1H3D;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 4 Heteromer
P0DTD1;
4271-4385
MES;A1H3E;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 6 Heteromer
P0DTD1;
4271-4385
MES;A1H3A;GOL;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 8 Heteromer
P0DTD1;
4271-4385
MES;A1H29;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 10 Heteromer
P0DTD1;
4271-4385
A1H4B;MES;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 9 Heteromer
P0DTD1;
4271-4385
A1H4C;MES;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 2 Heteromer
P0DTD1;
4271-4385
MES;A1H3B;GOL;ZN;
Assess
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 2 Heteromer
P0DTD1;
4271-4385
MES;A1H3C;ZN;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2g9t.1.Ahomo-12-mer0.804261-4382
24×ZN;97.12
Assess
6w4h.1.Bmonomer0.774271-4386
ZN;100.00
Assess